Condition: Schizophrenia · Sponsor: University of Aarhus
The objective of this study is to recruit patients at the first diagnosis with a schizophrenia spectrum disorder (SSD) and ultra-high risk patients (UHR), defined as patients with drug abuse and psychotic symptoms indicating a risk for developing schizophrenia. Thereby, the investigators aim to establish a large representative cohort of patients with a first-episode SSD or patients at UHR, enabling investigations of the etiology and long-term prognosis of SSDs. The primary aim is to learn more about the importance of adverse childhood experiences (ACEs) and the immune system in the etiology and course of schizophrenia. Patients will be followed with planned visits after 1, 2, 3, 12 and 24 months including online questionnaires after 2, 6, 10 and 26 weeks. There will be the possibility to contact patients again for subsequent follow-up visits.
This description comes directly from the study's public registry record.
Ole Köhler-Forsberg, MD, PhD · 0045 78471610 · karkoe@rm.dk
Always discuss trial participation with your own doctor first.
| Aarhus University Hospital Psychiatry | Aarhus, Denmark | Recruiting |
| Psychiatric Hospital Gødstrup | Herning, Denmark | Recruiting |
| Psychiatric Hospital Horsens | Horsens, Denmark | Recruiting |
| Psychiatric Hospital Randers | Randers, Denmark | Recruiting |
| Psychiatric Hospital Midt | Silkeborg, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06431009